AlphaCentric was founded in 2014 with the goal of providing financial advisors and their clients access to distinctive, innovative, alpha-driven investment strategies. The investment strategies implemented in our current fund lineup were once only available to institutional investors and large endowment plans. Our award-winning funds seek to address the needs of investors by generating alpha, reducing volatility, limiting tail risk, mitigating interest rate risk, and generating income. Visit us at: www.alphacentricfunds.com
5 Robotics Ideas from Q2 2020
Understanding durable industry trends and how they affect the companies in our universe is our core competency. Applying this understanding through superior stock picking is how we aim to distinguish our ourselves from the indexes. Here are just five key examples of this value proposition at work.
The Tipping Point of Robotics
We believe that the growth in robotics for workplace automation has reached a tipping point toward wide-scale adoption.
Medical and Healthcare Robotics
The global robotic surgery devices market is expected to decline from $5.04 billion in 2019 to $4.84 billion in 2020 at a rate of -3.91%. The decline is mainly due to the Covid-19 outbreak resulting in other patients delaying their episodes of care. The market is then expected to stabilize and reach $7.71 billion in 2023 at CAGR of 16.81%.
FLIR Systems, Inc. Overview
The Impact of 5G on Robotics & Automation
5G promises to provide 10X the speed of current bandwidth. It enables a new kind of network that is designed to connect virtually everyone and everything together
Immediate Catalysts for Investing in the Robotics Market
Technologies such as smart warehouses, automated manufacturing, robotic process automation, tele-medicine and medical automation can facilitate continued productivity during such events in reducing the spread of such viruses by minimizing the need for human contact.
Teladoc During The Covid-19 Crisis – Preliminary Quarterly Report
According to Teladoc’s first quarter 2020 preliminary results, the telemedicine company’s appointments have doubled to 20,000 a day as the pandemic has reshaped health care.
Stereotaxis Receives FDA Clearance For Genesis Robotic Magnetic Navigation System
Stereotaxis, with offices in St. Louis and the Netherlands, has won FDA clearance for the Genesis RMN System, a new generation of the company’s robotic navigation systems for the delivery of magnetic ablation catheters to address arrhythmias.
Intuitive Surgical Acquires Orpheus Medical: A Look Into Orpheus
Intuitive Surgical announced on February 10th, 2020 that it has acquired privately held Orpheus Medical to grow its integrated informatics platform. The terms of the transaction were not disclosed and Intuitive Surgical has said that Orpheus Medical will become a wholly-owned subsidiary of the company.
Stereotaxis – Patient Care with Robotic Precision
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures.
A Look into GEA Group
GEA provides sustainable solutions for sophisticated production processes in diverse end-user markets and offers a comprehensive service portfolio. The company is listed on the German MDAX, the STOXX Europe 600 Index and selected MSCI Global Sustainability Indexes.